PurposeAllosensitization is associated with post-transplant complications in heart transplant (HT) recipients. Lymphocyte-depleting induction may mitigate these risks, but efficacy data conflicting.MethodsThis single center, retrospective cohort study compared highly sensitized HT recipients (cPRA ≥50%) receiving lymphocyte-depleting vs. no from 2015-2021. The primary outcome was a composite of...